{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T10:48:43Z","timestamp":1778237323349,"version":"3.51.4"},"reference-count":43,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T00:00:00Z","timestamp":1639180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Psoriasis is an autoimmune and inflammatory skin disease. Psoriatic patients express higher levels of plasma homocysteine (Hcy) concentration and pro-inflammatory mediators than healthy people; this is frequently associated with vitamin D deficiency. The aim of this clinical study was to investigate the effects of high doses of vitamin D supplementation on the parameters of Hcy metabolism and cytokines in sera of psoriatic patients. This prospective study was conducted on 40 psoriatic patients who had the vitamin D deficiency. All patients received vitamin D 5000 IU\/day for three months. Clinical and biochemical measurements were taken at baseline and at follow up (3 months). The results showed that the severity of clinical features, measured by the psoriasis area severity index (PASI) score, were considerably improved in patients after vitamin D supplementation. After vitamin D supplementation, most of the patients (n = 25 or 62.5%) had mild clinical form (p &lt; 0.001). After twelve weeks of intervention period, there were significant increases in vitamin D and B12 serum levels in comparison to the levels that had been measured at the beginning of the study (56.77 \u00b1 14.66 nmol\/L and 301.08 \u00b1 95.02 pg\/mL vs. 103.85 \u00b1 32.20 nmol\/L and 362.81 \u00b1 118.56 pg\/mL, respectively; p &lt; 0.001). Moreover, serum levels of Hcy and folate were significantly lower at the end of the study in comparison with the initial levels (12.45 \u00b1 1.92 \u00b5mol\/L and 8.01 \u00b1 3.88 mg\/mL vs. 10.38 \u00b1 1.66 \u00b5mol\/L and 6.27 \u00b1 2.60 mg\/mL, respectively). High doses of vitamin D supplementation led to a significant decrease in pro-inflammatory cytokines (IFN-\u0264, TNF-\u03b1, IL-1\u03b2, IL-6, IL-8, and IL-17) and high-sensitivity C-reactive protein (hsCRP), whereas the production of anti-inflammatory cytokines (IL-10, IL-5) was up-regulated. In conclusion, supplementation with high doses of vitamin D could be one of the possible preventive and therapeutic measures to reduce systemic inflammation in psoriatic patients.<\/jats:p>","DOI":"10.3390\/biom11121865","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T01:28:11Z","timestamp":1639358891000},"page":"1865","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The Effect of Three-Month Vitamin D Supplementation on the Levels of Homocysteine Metabolism Markers and Inflammatory Cytokines in Sera of Psoriatic Patients"],"prefix":"10.3390","volume":"11","author":[{"given":"Alma","family":"Prtina","sequence":"first","affiliation":[{"name":"Center for Biomedical Research, Department of Pathophysiology, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nela","family":"Ra\u0161eta Simovi\u0107","sequence":"additional","affiliation":[{"name":"Center for Biomedical Research, Department of Pathophysiology, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Milivojac","sequence":"additional","affiliation":[{"name":"Center for Biomedical Research, Department of Pathophysiology, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milorad","family":"Vujni\u0107","sequence":"additional","affiliation":[{"name":"Center for Biomedical Research, Department of Pathophysiology, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7770-6293","authenticated-orcid":false,"given":"Milkica","family":"Grabe\u017e","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2196-9438","authenticated-orcid":false,"given":"Dragan","family":"Djuric","sequence":"additional","affiliation":[{"name":"Institute of Medical Physiology \u201cRichard Burian\u201d, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9431-0736","authenticated-orcid":false,"given":"Milo\u0161 P.","family":"Stojiljkovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Soldat Stankovi\u0107","sequence":"additional","affiliation":[{"name":"Internal Medicine Clinic, University Clinical Center of the Republic of Srpska, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miodrag J.","family":"\u010coli\u0107","sequence":"additional","affiliation":[{"name":"Medical Faculty Fo\u010da, University of East Sarajevo, 73300 Fo\u010da, Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranko","family":"\u0160krbi\u0107","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"16322","DOI":"10.1038\/s41598-019-52892-1","article-title":"Calcipotriol and betamethasone dipropionate synergistically enhances the balance between regulatory and proinflammatory T cells in a murine psoriasis model","volume":"9","author":"Satake","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Petit, R.G., Cano, A., Ortiz, A., Espina, M., Prat, J., Mu\u00f1oz, M., Severino, P., Souto, E.B., Garc\u00eda, M.L., and Pujol, M. (2021). Psoriasis: From pathogenesis to pharmacological and nano-technological-based therapeutics. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094983"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jaci.2017.07.033","article-title":"Inhibition of IL-17\u2013committed T cells in a murine psoriasis model by a vitamin D analogue","volume":"141","author":"Kusuba","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000485132","article-title":"Vitamin D and the pathophysiology of inflammatory skin diseases","volume":"31","author":"Umar","year":"2018","journal-title":"Skin Pharmacol. Physiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"276079","DOI":"10.1155\/2011\/276079","article-title":"Systemic role for vitamin D in the treatment of psoriasis and metabolic syndrome","volume":"2011","author":"Fu","year":"2011","journal-title":"Dermatol. Res. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e123390","DOI":"10.1172\/jci.insight.123390","article-title":"Disrupting the IL-36 and IL-23\/IL-17 loop underlies the efficacy of calcipotriol and corticosteroid therapy for psoriasis","volume":"4","author":"Wei","year":"2019","journal-title":"JCI Insight"},{"key":"ref_8","first-page":"17","article-title":"The role of regulatory T cells and anti-inflammatory cytokines in psoriasis","volume":"27","author":"Placek","year":"2018","journal-title":"Acta Dermatovenerol. Alp. Pannonica Adriat."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5114\/ada.2018.78028","article-title":"Serum concentration of interleukin 6 is related to inflammation and dyslipidemia in patients with psoriasis","volume":"37","author":"Pietrzak","year":"2020","journal-title":"Adv. Dermatol. Allergol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/15230860260220175","article-title":"Oxidative stress and its role in skin disease","volume":"4","author":"Trouba","year":"2002","journal-title":"Antioxid. Redox Signal."},{"key":"ref_11","first-page":"e2195","article-title":"Psoriasis and cardiovascular diseases: A literature review to determine the causal relationship","volume":"10","author":"Jindal","year":"2018","journal-title":"Cureus"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2133.2007.07986.x","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: A hospital-based case control study","volume":"157","author":"Gisondi","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1139\/cjpp-2018-0112","article-title":"Homocysteine and homocysteine-related compounds: An overview of the roles in the pathology of the cardiovascular and nervous systems","volume":"96","author":"Djuric","year":"2018","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1177\/039463201002300327","article-title":"Homocysteine, vitamin B 12 and folic acid levels in psoriatic patients and correlation with disease severity","volume":"23","author":"Brazzelli","year":"2010","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1538-7836.2005.01141.x","article-title":"Homocysteine, MTHFR and risk of venous thrombosis: A meta-analysis of published epidemiological studies","volume":"3","author":"Lewington","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e.126","DOI":"10.5114\/amsad.2016.64165","article-title":"Assessment of subclinical cardiac damage in chronic plaque psoriasis patients: A case control study","volume":"7","author":"Ozden","year":"2016","journal-title":"Arch. Med. Sci. Atheroscler. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"BSR20190867","DOI":"10.1042\/BSR20190867","article-title":"Homocysteine and psoriasis","volume":"39","author":"Lin","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0009-8981(03)00082-2","article-title":"Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients","volume":"332","author":"Uydu","year":"2003","journal-title":"Clin. Chim. Acta"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/S0007114513001840","article-title":"A Systematic review of vitamin D status in populations worldwide","volume":"111","author":"Hilger","year":"2014","journal-title":"Br. J. Nutr."},{"key":"ref_20","first-page":"155","article-title":"Correlation between plasmatic levels of vitamin D and PASI score","volume":"153","author":"Mattozzi","year":"2018","journal-title":"G. Ital. Dermatol. Venereol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1210\/jc.2013-3262","article-title":"The relationship between 25-hydroxyvitamin D and homocysteine in asymptomatic adults","volume":"99","author":"Amer","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.nutres.2018.07.012","article-title":"Vitamin D3 prevents cardiovascular diseases by lowering serum total homocysteine concentrations in overweight reproductive women: A randomized, placebo-controlled clinical trial","volume":"59","author":"Hamadneh","year":"2018","journal-title":"Nutr. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000083509","article-title":"The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis","volume":"210","author":"Schmitt","year":"2005","journal-title":"Dermatology"},{"key":"ref_24","first-page":"16","article-title":"Vitamin D deficiency and cardiovascular diseases","volume":"16","author":"Ciccone","year":"2015","journal-title":"G. Ital. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"McCullough, P.J., McCullough, W.P., Lehrer, D., Travers, J.B., and Repas, S.J. (2021). Oral and topical vitamin D, sunshine, and UVB phototherapy safely control psoriasis in patients with normal pretreatment serum 25-hydroxyvitamin D concentrations: A literature review and discussion of health implications. Nutrients, 13.","DOI":"10.20944\/preprints202103.0061.v1"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11154-017-9411-6","article-title":"Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist","volume":"18","author":"Barrea","year":"2017","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/WNL.59.4.529","article-title":"Homocysteine, MTHFR 677C->T polymorphism, and risk of ischemic stroke: Results of a meta-analysis","volume":"59","author":"Kelly","year":"2002","journal-title":"Neurology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2133.2006.07503.x","article-title":"Plasma homocysteine and folate levels in patients with chronic plaque psoriasis: Hyperhomocysteinaemia and psoriasis","volume":"155","author":"Malerba","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1468-3083.2008.03024.x","article-title":"Homocysteine, vitamin B12 and folic acid levels in psoriasis patients","volume":"23","author":"Soylu","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4274\/turkderm.22566","article-title":"Blood homocysteine, folic acid, vitamin B12 and vitamin B6 levels in psoriasis patients","volume":"39","author":"Uslu","year":"2017","journal-title":"Turkderm"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.18632\/oncotarget.22260","article-title":"Serum levels of adipokines and cytokines in psoriasis patients: A systematic review and meta-analysis","volume":"9","author":"Bai","year":"2018","journal-title":"Oncotarget"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/09674845.2016.1207869","article-title":"Immunophenotyping of T cells in the peripheral circulation in psoriasis","volume":"73","author":"Priyadarssini","year":"2016","journal-title":"Br. J. Biomed. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/sji.12304","article-title":"The vitamin D analogue calcipotriol reduces the frequency of CD8 + IL-17 + T cells in psoriasis lesions","volume":"82","author":"Bonefeld","year":"2015","journal-title":"Scand. J. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaci.2016.03.048","article-title":"Topical application of a vitamin D3 analogue and corticosteroid to psoriasis plaques decreases skin infiltration of TH17 cells and their ex vivo expansion","volume":"138","author":"Fujiyama","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/1744666X.2017.1279054","article-title":"The role of IL-4 in psoriasis","volume":"13","author":"Hahn","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.4049\/jimmunol.1401740","article-title":"IL-4 Downregulates IL-1\u03b2 and IL-6 and induces GATA3 in psoriatic epidermal cells: Route of action of a Th2 cytokine","volume":"195","author":"Onderdijk","year":"2015","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nm804","article-title":"Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease","volume":"9","author":"Ghoreschi","year":"2003","journal-title":"Nat. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","article-title":"Hyperhomocysteinemia: An indepedent risk factor for cardiovascular disease","volume":"324","author":"Clarke","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/01.STR.0000032550.90046.38","article-title":"Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland","volume":"33","author":"McIlroy","year":"2002","journal-title":"Stroke"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.CIR.101.4.372","article-title":"Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes","volume":"101","author":"Philippou","year":"2000","journal-title":"Circulation"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0923-1811(94)90018-3","article-title":"Regulatory effects of 1, 25-dihydroxyvitamin D3 and a novel vitamin D3 analogue MC903 on secretion of interleukin-1 alpha (IL-1\u03b1) and IL-8 by normal human keratinocytes and a human squamous cell carcinoma cell line (HSC-1)","volume":"7","author":"Zhang","year":"1994","journal-title":"J. Dermatol. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/jdv.13023","article-title":"Homocysteine plasma levels in psoriasis patients: Our experience and review of the literature","volume":"29","author":"Giannoni","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/12\/1865\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:45:35Z","timestamp":1760168735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/12\/1865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,11]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["biom11121865"],"URL":"https:\/\/doi.org\/10.3390\/biom11121865","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,11]]}}}